Breast cancer and spider telangiectasias at diagnosis and its relation to histopathology and prognosis: A population-based study

Breast Cancer Research and Treatment

Volumn 131, Issue 1, 2012, Pages 177-186

  Ellberg, Carolina ^a   Jernström, Helena ^a   Olsson, Håkan ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Angiogenesis; Breast cancer; Hormone influence; Hormone replacement therapy; Oral contraceptive pills; Spider telangiectasia

Indexed keywords

HORMONE RECEPTOR;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; BREAST CANCER; CANCER HORMONE THERAPY; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PARITY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TELANGIECTASIA;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RISK FACTORS; TELANGIECTASIS; YOUNG ADULT;

EID: 84856235790     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1707-8     Document Type: Article

References (30)

1. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 10647931 10.1016/S0092-8674(00)81683-9 1:CAS:528:DC%2BD3cXks1CktA%3D%3D (Pubitemid 30046295)
2. Longatto Filho A, Lopes JM, Schmitt FC (2010) Angiogenesis and breast cancer. J Oncol. doi: 10.1155/2010/576384
3. C Dabrosin 2005 Sex steroid regulation of angiogenesis in breast tissue Angiogenesis 8 2 127 136 10.1007/s10456-005-9002-0 16211362 10.1007/s10456-005- 9002-0 1:CAS:528:DC%2BD2MXht1GlsL%2FP (Pubitemid 41712842)
4. K Sengupta S Banerjee N Saxena SK Banerjee 2003 Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway Int J Oncol 22 3 609 614 12579315 1:CAS:528:DC%2BD3sXhslKru7o%3D
5. SM Hyder Z Nawaz C Chiappetta GM Stancel 2000 Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor Cancer Res 60 12 3183 3190 10866309 1:CAS:528:DC%2BD3cXktlyktbc%3D (Pubitemid 30407915)
6. J Delli Carpini AK Karam L Montgomery 2010 Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer Angiogenesis 13 1 43 58 10.1007/s10456-010-9163-3 20229258 10.1007/s10456-010-9163-3
7. JH Solem 1952 Cutaneous arterial spiders following use of adrenocorticotropic hormone Lancet 2 6748 1241 1242 13011904 10.1016/S0140-6736(52)90844-1 1:STN:280:DyaG3s%2Fjs1CitA%3D%3D
8. Requena L, Sangueza OP (1997) Cutaneous vascular anomalies. Part I. Hamartomas, malformations, and dilation of preexisting vessels. J Am Acad Dermatol 37(4):523-549; quiz 549-552. doi: 10.1016/S0190-9622(97)70169-5 (Pubitemid 27446722)
9. CP Li FY Lee SJ Hwang FY Chang HC Lin RH Lu MC Hou CJ Chu CC Chan JC Luo SD Lee 1999 Spider angiomas in patients with liver cirrhosis: role of alcoholism and impaired liver function Scand J Gastroenterol 34 5 520 523 10423070 10.1080/003655299750026272 1:STN:280:DyaK1MzkvF2gsQ%3D%3D (Pubitemid 29307824)
10. CP Li FY Lee SJ Hwang RH Lu WP Lee Y Chao SS Wang FY Chang J Whang-Peng SD Lee 2003 Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor World J Gastroenterol 9 12 2832 2835 14669345 1:CAS:528:DC%2BD2cXmt1Cktw%3D%3D (Pubitemid 38054472)
11. T Key P Appleby I Barnes G Reeves 2002 Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 8 606 616 11959894 1:CAS:528:DC%2BD38Xjs1eit7w%3D (Pubitemid 34498648)
12. M Shibuya 2008 Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis BMB Rep 41 4 278 286 18452647 10.5483/BMBRep.2008.41.4.278 1:CAS:528:DC%2BD1cXlvFelsL0%3D (Pubitemid 351656921)
13. D Coradini C Pellizzaro S Veneroni L Ventura MG Daidone 2002 Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence Br J Cancer 87 10 1105 1111 10.1038/sj.bjc.6600556 12402149 10.1038/sj.bjc. 6600556 1:CAS:528:DC%2BD38XotFWrtbo%3D (Pubitemid 35418105)
14. C Dabrosin 2003 Variability of vascular endothelial growth factor in normal human breast tissue in vivo during the menstrual cycle J Clin Endocrinol Metab 88 6 2695 2698 12788875 10.1210/jc.2002-021584 1:CAS:528: DC%2BD3sXkslCrs70%3D (Pubitemid 36724444)
15. C Dabrosin 2005 Positive correlation between estradiol and vascular endothelial growth factor but not fibroblast growth factor-2 in normal human breast tissue in vivo Clin Cancer Res 11 22 8036 8041 10.1158/1078-0432.CCR-05- 0977 16299233 10.1158/1078-0432.CCR-05-0977 1:CAS:528:DC%2BD2MXht1entr%2FM (Pubitemid 41698745)
16. C Dabrosin PJ Margetts J Gauldie 2003 Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer Int J Cancer 107 4 535 540 10.1002/ijc.11398 14520689 10.1002/ijc.11398 1:CAS:528:DC%2BD3sXoslequ7o%3D (Pubitemid 37296112)
17. C Dabrosin K Palmer WJ Muller J Gauldie 2003 Estradiol promotes growth and angiogenesis in polyoma middle T transgenic mouse mammary tumor explants Breast Cancer Res Treat 78 1 1 6 12611451 10.1023/A:1022133219353 1:CAS:528:DC%2BD3sXntV2rsg%3D%3D (Pubitemid 36223011)
18. S Garvin C Dabrosin 2003 Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo Cancer Res 63 24 8742 8748 14695189 1:CAS:528:DC%2BD3sXhtVSqtb7P (Pubitemid 38064052)
19. S Garvin C Dabrosin 2008 In vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patients BMC Cancer 8 73 10.1186/1471-2407-8-73 18366667 10.1186/1471-2407-8-73 (Pubitemid 351516592)
20. S Garvin UW Nilsson C Dabrosin 2005 Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells Br J Cancer 93 9 1005 1010 10.1038/sj.bjc.6602824 16234819 10.1038/sj.bjc.6602824 1:CAS:528:DC%2BD2MXhtFChsL3F (Pubitemid 41548394)
21. UW Nilsson A Abrahamsson C Dabrosin 2010 Angiogenin regulation by estradiol in breast tissue: tamoxifen inhibits angiogenin nuclear translocation and antiangiogenin therapy reduces breast cancer growth in vivo Clin Cancer Res 16 14 3659 3669 10.1158/1078-0432.CCR-10-0501 20501617 10.1158/1078-0432.CCR-10- 0501 1:CAS:528:DC%2BC3cXovVantr4%3D
22. AM Jubb AL Harris 2010 Biomarkers to predict the clinical efficacy of bevacizumab in cancer Lancet Oncol 11 12 1172 1183 10.1016/S1470-2045(10)70232-1 21126687 10.1016/S1470-2045(10)70232-1 1:CAS:528:DC%2BC3cXhsVyhsLbP
23. AM Fair K Montgomery 2009 Energy balance, physical activity, and cancer risk Methods Mol Biol 472 57 88 10.1007/978-1-60327-492-0-3 19107429 10.1007/978-1-60327-492-0-3
24. M Chavez-MacGregor SG Elias NC Onland-Moret YT van der Schouw CH Van Gils E Monninkhof DE Grobbee PH Peeters 2005 Postmenopausal breast cancer risk and cumulative number of menstrual cycles Cancer Epidemiol Biomarkers Prev 14 4 799 804 10.1158/1055-9965.EPI-04-0465 15824146 10.1158/1055-9965.EPI-04-0465 (Pubitemid 40478538)
25. M Chavez-MacGregor CH van Gils YT van der Schouw E Monninkhof PA van Noord PH Peeters 2008 Lifetime cumulative number of menstrual cycles and serum sex hormone levels in postmenopausal women Breast Cancer Res Treat 108 1 101 112 10.1007/s10549-007-9574-z 18274909 10.1007/s10549-007-9574-z 1:CAS:528:DC%2BD1cXitVKmtL0%3D (Pubitemid 351623234)
26. H Jernstrom J Frenander M Ferno H Olsson 1999 Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients Br J Cancer 80 9 1453 1458 10.1038/sj.bjc.6690543 10424750 10.1038/sj.bjc.6690543 1:STN:280: DyaK1Mzlt1SgtA%3D%3D (Pubitemid 29308617)
27. H Olsson 2000 Tumour biology of a breast cancer at least partly reflects the biology of the tissue/epithelial cell of origin at the time of initiation-a hypothesis J Steroid Biochem Mol Biol 74 5 345 350 10.1016/s0960-0760(00)00111-4 11162943 10.1016/S0960-0760(00)00111-4 1:CAS:528:DC%2BD3MXitFyjug%3D%3D (Pubitemid 32126245)
28. CI Li DJ Uribe Jr. Daling 2005 Clinical characteristics of different histologic types of breast cancer Br J Cancer 93 9 1046 1052 10.1038/sj.bjc.6602787 16175185 10.1038/sj.bjc.6602787 1:STN:280: DC%2BD2MrntFWrsQ%3D%3D (Pubitemid 41548400)
29. Y Cao GP Paner LB Kahn PB Rajan 2004 Noninvasive carcinoma of the breast: angiogenesis and cell proliferation Arch Pathol Lab Med 128 8 893 896 15270612 (Pubitemid 39014123)
30. M Duarte A Longatto Filho FC Schmitt 2007 Angiogenesis, haemostasis and cancer: new paradigms and old concerns J Bras Patol Med Lab 43 441 449 10.1590/S1676-24442007000600009